News

More questions about Prasad’s return

BACK TO CBER — Dr. Vinay Prasad has returned to the FDA’s Center for Biologics Evaluation and Research, leaving industry and ...
Pulmonology Advisor39m

Vinay Prasad Returns to FDA After Being Ousted

The FDA’s top vaccine regulator is returning to his post less than 2 weeks after the White House had him ousted.
The BMJ5h

Vinay Prasad reinstated to FDA vaccines role, 14 days after resignation

Vinay Prasad was reinstated as the head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug ...
BioSpace50m

Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues

CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...
JD Supra19h

The Return of CBER Director Prasad, FDA Announces New Chief Counsel, and FDA Budget Watch

In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...
STAT21h

Prasad returns to the FDA, Attack on the CDC

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...